20.11
Enliven Therapeutics Inc 주식(ELVN)의 최신 뉴스
Why retail investors favor Enliven Therapeutics Inc. stockEarnings Summary Report & Free Real-Time Volume Trigger Notifications - newser.com
Chart based exit strategy for Enliven Therapeutics Inc.Trade Volume Summary & Daily Chart Pattern Signals - newser.com
Will Enliven Therapeutics Inc. stock recover after recent dropQuarterly Trade Summary & Verified Short-Term Plans - newser.com
Enliven Therapeutics CFO sells $22,524 in stock - MSN
Long term hold vs stop loss in Enliven Therapeutics Inc.Quarterly Risk Review & Weekly Market Pulse Alerts - newser.com
Is now a turning point for Enliven Therapeutics Inc.Insider Buying & Stepwise Trade Signal Guides - newser.com
Top chart patterns to watch in Enliven Therapeutics Inc.2025 Big Picture & Weekly High Return Opportunities - newser.com
Will Enliven Therapeutics Inc. rebound enough to break even2025 Top Decliners & Weekly High Potential Stock Alerts - newser.com
Developing predictive dashboards with Enliven Therapeutics Inc. dataQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
What analysts say about Enliven Therapeutics Inc stockGlobal Market Influence & Investment Case Studies - earlytimes.in
How to manage a losing position in Enliven Therapeutics Inc.2025 Valuation Update & Precise Buy Zone Identification - newser.com
Head-To-Head Analysis: Enliven Therapeutics (NASDAQ:ELVN) vs. Crinetics Pharmaceuticals (NASDAQ:CRNX) - Defense World
Brokerages Set Enliven Therapeutics, Inc. (NASDAQ:ELVN) Price Target at $41.20 - Defense World
Enliven Therapeutics Inc Stock Analysis and ForecastFundamental Strength Indicators & Low Risk Wealth Building - Early Times
Enliven Therapeutics (NASDAQ:ELVN) Trading 7.2% HigherTime to Buy? - MarketBeat
Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) CEO Sells 2,800 Shares of Stock - MarketBeat
Enliven Therapeutics (NASDAQ:ELVN) Insider Joseph Lyssikatos Sells 1,500 Shares - MarketBeat
Enliven Therapeutics CSO sells $30,045 in shares By Investing.com - Investing.com Canada
Enliven Therapeutics, Inc. (NASDAQ:ELVN) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Enliven Therapeutics CSO sells shares worth $135,697 - Investing.com India
Enliven Therapeutics CSO sells shares worth $135,697 By Investing.com - Investing.com Canada
Enliven Therapeutics (NASDAQ:ELVN) Insider Joseph Lyssikatos Sells 7,000 Shares - MarketBeat
Samuel Kintz Sells 5,000 Shares of Enliven Therapeutics (NASDAQ:ELVN) Stock - MarketBeat
Insider Selling: Enliven Therapeutics (NASDAQ:ELVN) CEO Sells 1,000 Shares of Stock - MarketBeat
Enliven Therapeutics, Inc. $ELVN Shares Purchased by Goldman Sachs Group Inc. - MarketBeat
자본화:
|
볼륨(24시간):